Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Urenco Stable Isotopes is a specialized business unit of the Urenco Group that utilizes advanced gas centrifuge technology to produce a diverse range of enriched stable and radioactive isotopes. The company is a critical supplier to the life sciences and healthcare industries, providing essential precursors for radiopharmaceuticals used in diagnostic imaging and cancer therapy. Their products support medical applications such as PET and SPECT scans, as well as industrial and research sectors including semiconductor manufacturing and quantum computing. Based in Almelo, Netherlands, the company operates high-tech enrichment facilities and continues to expand its capacity to meet the growing global demand for medical isotopes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Urenco Stable Isotopes.